Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRestructuring CostsRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Cross Country Healthcare (CCRN) Income from Non-Controlling Interests (2016 - 2020)

Cross Country Healthcare's Income from Non-Controlling Interests history spans 7 years, with the latest figure at $210000.0 for Q4 2020.

  • For Q4 2020, Income from Non-Controlling Interests fell 61.4% year-over-year to $210000.0; the TTM value through Sep 2021 reached $210000.0, down 81.8%, while the annual FY2020 figure was $820000.0, 53.67% down from the prior year.
  • Income from Non-Controlling Interests reached $210000.0 in Q4 2020 per CCRN's latest filing, up from $186000.0 in the prior quarter.
  • In the past five years, Income from Non-Controlling Interests ranged from a high of $544000.0 in Q4 2019 to a low of $103000.0 in Q2 2020.
  • Average Income from Non-Controlling Interests over 5 years is $293850.0, with a median of $299000.0 recorded in 2017.
  • Peak YoY movement for Income from Non-Controlling Interests: surged 160.56% in 2017, then tumbled 74.5% in 2020.
  • A 5-year view of Income from Non-Controlling Interests shows it stood at $235000.0 in 2016, then surged by 30.21% to $306000.0 in 2017, then increased by 13.73% to $348000.0 in 2018, then surged by 56.32% to $544000.0 in 2019, then crashed by 61.4% to $210000.0 in 2020.
  • Per Business Quant, the three most recent readings for CCRN's Income from Non-Controlling Interests are $210000.0 (Q4 2020), $186000.0 (Q3 2020), and $103000.0 (Q2 2020).